drug

relugolix, estradiol hemihydrate, and norethindrone acetate

1 story · latest Jul 6, 2026

Status: FDA approved May 2021 · NDA214846
Brand: Myfembree

Relationships

Developed by Sumitomo Pharma

Timeline

AbCellera appoints Lynn Seely to board of directors

Jul 6PeopleAbCellera Biologics Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.